SGS Announces Appointments at New Facility in California - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SGS Announces Appointments at New Facility in California


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 6

SGS Life Science Services reported two senior appointments at its new GMP/GLP laboratory in Carson, CA, which is due to open in the third quarter of 2014.

Marcella McSorley joins SGS as QA manager, and will have a role in the implementation of a quality management system at the new site. McSorley previously served as the director of quality control for Aaron Industries. SGS has also appointed Pojaman Zunggeemoge as microbiology manager. Zunggeemoge will focus on the management of the microbiology department at Carson and ensure the on-going compliance with SOPs. She joins SGS from Grifols Biologicals, where she was the QC microbiology supervisor.

The 7,500 ft2 Carson facility will offer microbiological testing and bioanalytical services in a GMP/GLP controlled environment. This will be SGS’s fifth North American site in addition to its facilities in Fairfield, NJ, Lincolnshire, IL, West Chester, PA, and Mississauga, ON.

Source: SGS Life Science Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here